Ferring Pharmaceuticals is committed to getting you the resources you need.
Ferring Access Support—Patient Assistance Program (PAP)
This program offers patient assistance, coverage support, and other valuable resources for eligible uninsured/underinsured patients, including:
- Referrals to third-party organizations including 501(c)(3) charities, patient support and education groups, and state health exchange resources
- Help with scheduling appointments and staying on top of treatment
You could receive ADSTILADRIN at REDUCED OR NO COST*
ENROLL
Your healthcare team will help you enroll in the program.
GET SUPPORT
After that, a Ferring Access Support Case Manager will contact you to help you learn more about what to expect during the treatment process.
STAY SUPPORTED
They may also reach out if there is any missing information in your profile or to remind you of an upcoming appointment.
ADSTILADRIN Copay Program
Eligible, commercially insured patients may
pay as little as $100†
for each ADSTILADRIN prescription
Financial support for patients
1-844-NADOnow (1-844-623-6669)1-844-NADOnow (1-844-623-6669)
Monday to Friday, 9 AM to 6 PM ET
Your Case Manager will work with your health insurer to determine whether your plan covers the cost
of ADSTILADRIN. They can also share information about other programs, such as the PAP or the ADSTILADRIN Copay Program, to help you access ADSTILADRIN. Terms and conditions apply.
*Terms and conditions apply.
†Available only for patients who meet eligibility requirements. Program does not cover the cost of administration, office visits, or any associated costs. Terms and conditions apply. Offer expires 12/31/24.
Important Safety Information
INDICATION
ADSTILADRIN is a treatment for adults who have all the following:
- High-risk non–muscle-invasive bladder cancer (NMIBC)
- Cancer that is not responding to Bacillus Calmette-Guérin (BCG) therapy
- Carcinoma in situ (CIS) with or without other high-grade tumors
IMPORTANT SAFETY INFORMATION
Who should not receive ADSTILADRIN?
Do not receive ADSTILADRIN if you have a sensitivity to interferon alfa or any of its components.
What is the most important information I should know about ADSTILADRIN?
Individuals who are immunosuppressed or immune-deficient should not prepare, administer, receive or come into contact with ADSTILADRIN.
What should I tell my healthcare provider?
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of ADSTILADRIN?
The most common side effects of ADSTILADRIN include:
Urinary discharge, fatigue, bladder spasm, urgency to urinate, and blood in your urine.
These are not all the possible side effects of ADSTILADRIN. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-10881-800-332-1088. You may also contact Ferring Pharmaceuticals at 1-888-FERRING1-888-FERRING.
What other information should I know about using ADSTILADRIN?
For 2 days following treatment, voided urine should be disinfected for 15 minutes with an equal volume of bleach before flushing.
For more important information, call 1-888-337-74641-888-337-7464.
Please see full Prescribing Information.